Literature DB >> 24269253

Concentration rather than dose defines the local brain toxicity of agents that are effectively distributed by convection-enhanced delivery.

Rong Zhang1, Ryuta Saito2, Yui Mano1, Masayuki Kanamori1, Yukihiko Sonoda1, Toshihiro Kumabe1, Teiji Tominaga1.   

Abstract

BACKGROUND: Convection-enhanced delivery (CED) has been developed as a potentially effective drug-delivery strategy into the central nervous system. In contrast to systemic intravenous administration, local delivery achieves high concentration and prolonged retention in the local tissue, with increased chance of local toxicity, especially with toxic agents such as chemotherapeutic agents. Therefore, the factors that affect local toxicity should be extensively studied. NEW
METHOD: With the assumption that concentration-oriented evaluation of toxicity is important for local CED, we evaluated the appearance of local toxicity among different agents after delivery with CED and studied if it is dose dependent or concentration dependent.
RESULTS: Local toxicity profile of chemotherapeutic agents delivered via CED indicates BCNU was dose-dependent, whereas that of ACNU was concentration-dependent. On the other hand, local toxicity for doxorubicin, which is not distributed effectively by CED, was dose-dependent. Local toxicity for PLD, which is extensively distributed by CED, was concentration-dependent. COMPARISON WITH EXISTING
METHOD: Traditional evaluation of drug induced toxicity was dose-oriented. This is true for systemic intravascular delivery. However, with local CED, toxicity of several drugs exacerbated in concentration-dependent manner. From our study, local toxicity of drugs that are likely to distribute effectively tended to be concentration-dependent.
CONCLUSION: Concentration rather than dose may be more important for the toxicity of agents that are effectively distributed by CED. Concentration-oriented evaluation of toxicity is more important for CED.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  4′,6-diamidino-2-phenylindole; ACNU; BBB; BCNU; Brain tumor; CED; Chemotherapy; Convection-enhanced delivery; DAPI; Drug delivery; NeuN; PBS; PEGylated liposomal doxorubicin; PLD; Toxicity; blood–brain barrier; carmustine; convection-enhanced delivery; neuronal nuclear antigen; nimustine hydrochloride; phosphate buffered saline

Mesh:

Substances:

Year:  2013        PMID: 24269253     DOI: 10.1016/j.jneumeth.2013.11.004

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  3 in total

1.  Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.

Authors:  Muna Aryal; Natalia Vykhodtseva; Yong-Zhi Zhang; Nathan McDannold
Journal:  J Control Release       Date:  2015-02-24       Impact factor: 9.776

Review 2.  Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.

Authors:  Ryuta Saito; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-12-15       Impact factor: 1.742

3.  Phase I trial of convection-enhanced delivery of nimustine hydrochloride (ACNU) for brainstem recurrent glioma.

Authors:  Ryuta Saito; Masayuki Kanamori; Yukihiko Sonoda; Yoji Yamashita; Kenichi Nagamatsu; Takaki Murata; Shunji Mugikura; Toshihiro Kumabe; Eva Wembacher-Schröder; Rowena Thomson; Teiji Tominaga
Journal:  Neurooncol Adv       Date:  2020-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.